Healthcare Professional

Welcome to the Rare Haematology Resource Centre. This site is intended for healthcare professionals in Australia and New Zealand only. By clicking the link below, you are declaring and confirming that you are a healthcare professional.

Rare Haematology Resource Centre

Research to advance your knowledge

The Rare Haematology Resource Centre highlights the development of therapies for diseases in rare haematology. In addition, it focuses on the actual research to advance your knowledge. We will offer content comprising of a combination of selected articles from peer-reviewed journals, patient case reports and KOL interviews. This freely available resource center is editorially independent and hosted by the Journal Molecular Genetics and Metabolism. New content will be posted monthly on this platform. Please subscribe to our e-Alert to ensure that you stay up to date with recent scientific developments.

Editors' picks of the month

Sign up for the e-alert

Sign up now

No thanks, I'm not interested
(closes after 5 sec.)

Latest Articles

Dr Ellen Sidransky, Rare Haematology Resource Centre editor, suggests a greater knowledge of rare diseases may help us better understand more common diseases

08 sidransky DEFdef

Prof Jeff Szer, Rare Haematology Resource Centre editor, explains why knowledge about rare diseases is so important

04.1 Jeff Szer Welcome to Resource Centre

Welcome! From the Editors

Jeff Szer

Disease Group Lead – non-malignant haematology Victorian Comprehensive Cancer Centre


Improving therapeutic outcomes

Rare diseases like Gaucher disease can be very challenging to diagnose and treat. Further understanding of lysosomal storage diseases will help overcome these challenges for improvement in therapy and therapeutic outcomes for our patients.

Ellen Sidransky

Clinical Geneticist and Gaucher Investigator from Bethesda, Maryland, USA

Journal editorial board member, Molecular Genetics and Metabolism

Understanding unique problems

This is a really pivotal time for research in the field of Gaucher disease. Our understanding of lysosomal storage diseases (LSDs) has broadened significantly since the approval of enzyme therapy more than 25 years ago, and in many ways,  Gaucher disease has become a beacon for other LSDs. Currently,  our appreciation of a link with Parkinsonism, has opened new avenues to explore These are indeed exciting times, yet there is still so much to understand.

The Rare Haematology Resource Centre is intended for healthcare professionals only.


Sign up for the e-mail alert to stay informed of new content updates about rare haematology.

The Rare Haematology Resource Centre is funded by Sanofi Genzyme and developed by Elsevier. Sanofi Genzyme has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subject to an independent editorial review. The content expressed are those of the individual experts and the editorial board governed by Elsevier and do not necessarily express the view of Sanofi Genzyme.